Literature DB >> 26967309

Reference values for the incremental shuttle walk test in patients with cardiovascular disease entering exercise-based cardiac rehabilitation.

Fernando M F Cardoso1, Meshal Almodhy1, Garyfalia Pepera2, Dimitrios M Stasinopoulos3, Gavin R H Sandercock1.   

Abstract

The incremental shuttle walk test (ISWT) is used to assess functional capacity of patients entering cardiac rehabilitation. Factors such as age and sex account for a proportion of the variance in test performance in healthy individuals but there are no reference values for patients with cardiovascular disease. The aim of this study was to produce reference values for the ISWT. Participants were n = 548 patients referred to outpatient cardiac rehabilitation who underwent a clinical examination and performed the ISWT. We used regression to identify predictors of performance and produced centile values using the generalised additive model for location, scale and shape model. Men walked significantly further than women (395 ± 165 vs. 269 ± 118 m; t = 9.5, P < 0.001) so data were analysed separately by sex. Age (years) was the strongest predictor of performance in men (β = -5.9; 95% CI: -7.1 to -4.6 m) and women (β = -4.8; 95% CI: -6.3 to 3.3). Centile curves demonstrated a broadly linear decrease in expected ISWT values in males (25-85 years) and a more curvilinear trend in females. Patients entering cardiac rehabilitation present with highly heterogeneous ISWT values. Much of the variance in performance can be explained by patients' age and sex. Comparing absolute values with age-and sex-specific reference values may aid interpretation of ISWT performance during initial patient assessment at entry to cardiac rehabilitation.

Entities:  

Keywords:  Cardiovascular disease; GAMLSS; centiles; functional capacity

Mesh:

Year:  2016        PMID: 26967309     DOI: 10.1080/02640414.2016.1151925

Source DB:  PubMed          Journal:  J Sports Sci        ISSN: 0264-0414            Impact factor:   3.337


  7 in total

1.  Results from the randomized controlled IHOPE trial suggest no effects of oral protein supplementation and exercise training on physical function in hemodialysis patients.

Authors:  Jin Hee Jeong; Annabel Biruete; Emily J Tomayko; Pei Tzu Wu; Peter Fitschen; Hae Ryong Chung; Mohamad Ali; Edward McAuley; Bo Fernhall; Shane A Phillips; Kenneth R Wilund
Journal:  Kidney Int       Date:  2019-04-02       Impact factor: 10.612

2.  Evaluation of determinants of walking fitness in patients attending cardiac rehabilitation.

Authors:  Jassas Fm Alotaibi; Patrick Doherty
Journal:  BMJ Open Sport Exerc Med       Date:  2017-03-10

3.  What factors are associated with patients walking fitness when starting cardiac rehabilitation?

Authors:  Martina Minotto; Alexander S Harrison; Giovanni Grazzi; Jonathan Myers; Patrick Doherty
Journal:  Int J Cardiol Heart Vasc       Date:  2018-11-23

4.  Determinants of walking fitness in patients with heart failure attending cardiac rehabilitation.

Authors:  Patrick Doherty; Alexander Stephen Harrison; Rashed Hossain
Journal:  Open Heart       Date:  2019-02-27

5.  The cardiovascular determinants of physical function in patients with end-stage kidney disease on haemodialysis.

Authors:  Sherna F Adenwalla; Roseanne E Billany; Daniel S March; Gaurav S Gulsin; Hannah M L Young; Patrick Highton; Darren C Churchward; Robin Young; Alysha Careless; Clare L Tomlinson; Gerry P McCann; James O Burton; Matthew P M Graham-Brown
Journal:  Int J Cardiovasc Imaging       Date:  2020-11-30       Impact factor: 2.357

6.  Comparison of heart rate response and heart rate recovery after step test among smoker and non-smoker athletes.

Authors:  Garyfallia Pepera; Zogka Panagiota
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

7.  Heart rate variability in children: methodological issues and clinical applications.

Authors:  Iván Rodríguez-Núñez; Natalia Rodríguez-Romero; Alejandro Álvarez; Lysien Zambrano; Glaucia Luciano da Veiga; Fernando Romero
Journal:  Arch Cardiol Mex       Date:  2022-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.